{
  "id" : "nodes_dby",
  "algorithm" : "eod_public",
  "version" : "1.0",
  "name" : "EOD Regional Nodes",
  "title" : "EOD Regional Nodes",
  "notes" : "**Note:** All lymph node (regional and distant) involvement is coded in this field.",
  "footnotes" : "1. Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n2. Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions,** National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n3. Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05.** American Joint Committee on Cancer (Chicago, IL)\n\n4. Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30\n\n5. Pollock, R.E., Maki, R.G. **Introduction to Soft Tissue Sarcoma** In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 489-497\n\n6. Maki, R.G., Pollock, R.E., et al. **Soft Tissue Sarcoma â€“ Unusual Histologies and Sites**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 539-545",
  "last_modified" : "2018-03-12T16:39:58.165Z",
  "definition" : [ {
    "key" : "eod_regional_nodes",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  }, {
    "key" : "eod_2018_n",
    "name" : "EOD 2018 N",
    "type" : "ENDPOINT"
  }, {
    "key" : "ss2018_n",
    "name" : "SS2018 N",
    "type" : "ENDPOINT"
  } ],
  "rows" : [ [ "000", "No lymph node involvement\n(No clinical adenopathy and either pathologically negative or no pathological statement)", "VALUE:88", "VALUE:NONE" ], [ "100", "Clinically enlarged palpable lymph node(s) (adenopathy),\nand either pathologically negative nodes or no pathological statement", "VALUE:88", "VALUE:RN" ], [ "200", "No clinically enlarged palpable lymph node(s) (adenopathy) but pathologically positive lymph node(s)", "VALUE:88", "VALUE:RN" ], [ "300", "Both clinically enlarged palpable lymph node(s) (adenopathy) and pathologically positive lymph node", "VALUE:88", "VALUE:RN" ], [ "800", "Regional lymph node(s), NOS\nLymph node(s), NOS", "VALUE:88", "VALUE:RN" ], [ "999", "Unknown; not stated\nRegional lymph node(s) cannot be assessed\nNot documented in patient record\n\nDeath Certificate Only", "VALUE:88", "VALUE:U" ] ]
}